# Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia

> **NCT05667402** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 50 (estimated)

## Conditions studied

- Central Nervous System Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** TBF regimen
- **DRUG:** modified BuCY2 regimen

## Key facts

- **NCT ID:** NCT05667402
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667402, "Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05667402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*